The data presents the financing data of U.S. biotech companies from 2012 to 2016. In 2016, private biotech companies raised some 8.6 billion USD of capital, while public companies raised some 25.6 billion USD.
Capital raised by public companies (in billion US$) | 18.9 | 20 | 37.8 | 51.5 | 25.6 |
Capital raised by private companies (in billion US$) | 4.8 | 5.7 | 7.3 | 9.6 | 8.6 |
Number of IPOs | 12 | 41 | 63 | 45 | 24 |